Abstract
Critically ill patients, particularly those under mechanical ventilation, require analgo-sedation to control noxious stimuli and enhance comfort. Despite their harmful side effects, such as respiratory depression, physical dependance and difficult arousal, opioids are effective in providing a good level of analgesia and comfort. Traditional opioids (morphine and fentanyl) have been shown effective in providing analgesia; however, the respiratory adverse effects and their pharmacokinetics, with an high risk of accumulation, limits their use, especially for a long-term sedation. In the last decade, new synthetic opioids with limited side effects and favourable pharmacokinetics profile, such as Sufentanil and Remifentanil, have been investigated to evaluate their efficacy in mitigating pain and enhancing comfort in critically ill patients.
Keywords: analgo-sedation, opioids, morphine, fentanyl, sufentanil, remifentanil
Current Drug Targets
Title: Analgesia in PACU: Intravenous Opioids
Volume: 6 Issue: 7
Author(s): G. Conti, R. Costa, A. Pellegrini, A. Craba and F. Cavaliere
Affiliation:
Keywords: analgo-sedation, opioids, morphine, fentanyl, sufentanil, remifentanil
Abstract: Critically ill patients, particularly those under mechanical ventilation, require analgo-sedation to control noxious stimuli and enhance comfort. Despite their harmful side effects, such as respiratory depression, physical dependance and difficult arousal, opioids are effective in providing a good level of analgesia and comfort. Traditional opioids (morphine and fentanyl) have been shown effective in providing analgesia; however, the respiratory adverse effects and their pharmacokinetics, with an high risk of accumulation, limits their use, especially for a long-term sedation. In the last decade, new synthetic opioids with limited side effects and favourable pharmacokinetics profile, such as Sufentanil and Remifentanil, have been investigated to evaluate their efficacy in mitigating pain and enhancing comfort in critically ill patients.
Export Options
About this article
Cite this article as:
Conti G., Costa R., Pellegrini A., Craba A. and Cavaliere F., Analgesia in PACU: Intravenous Opioids, Current Drug Targets 2005; 6 (7) . https://dx.doi.org/10.2174/138945005774574407
DOI https://dx.doi.org/10.2174/138945005774574407 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issues: Pharmacological Intervention for Down Syndrome Cognitive Deficits: Emerging Drug Targets)
CNS & Neurological Disorders - Drug Targets Major Developments in the Design of Inhibitors along the Kynurenine Pathway
Current Medicinal Chemistry Neurosteroids and Hepatic Encephalopathy: An Update on Possible Pathophysiologic Mechanisms
Current Molecular Pharmacology Hydrogen Sulphide and Pain
Inflammation & Allergy - Drug Targets (Discontinued) Apolipoprotein E Knockout Models
Current Pharmaceutical Design Treating Nonthyroidal Illness Syndrome in the Critically Ill Patient: Still a Matter of Controversy
Current Drug Targets Novel Hybrid Anticonvulsants Derived from Pyrrolidine-2,5-dione Scaffold with Broad Spectrum of Activity in the Preclinical Studies
Current Topics in Medicinal Chemistry The Evolving Roles of Nuclear Cardiology
Current Cardiology Reviews Hepatitis C Virus Clearance: The Enigma of Failure Despite an Impeccable Survival Strategy
Current Pharmaceutical Biotechnology Negative Affect and Drinking Drivers: A Review and Conceptual Model Linking Dissonance, Efficacy and Negative Affect to Risk and Motivation for Change
Current Drug Abuse Reviews Antiplatelets in Stroke Prevention
Current Vascular Pharmacology Biological Characteristics and Role of Histamine in Case of Allergic Rhinitis
Medicinal Chemistry Reviews - Online (Discontinued) The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
Current Pharmaceutical Biotechnology Skeletal Muscle Cell Behavior After Physical Agent Treatments
Current Pharmaceutical Design Epigenomic-Basis of Preemptive Medicine for Neurodevelopmental Disorders
Current Genomics In vitro Study of Furazano[3,4-b]quinoxaline 1-Oxides as Potential ΝΟ Releasing Agents
Letters in Drug Design & Discovery Neuroprotective Effects of Lithium - Pointing out Protein Phosphatases as Drug Targets?
Current Medicinal Chemistry - Central Nervous System Agents Editorial (Thematic Issue:Neuroscience of Exercise: Focus on Cognitive and Brain Functioning)
CNS & Neurological Disorders - Drug Targets Targeting Wnt Signaling through Small molecules in Governing Stem Cell Fate and Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews